Hiroki Tojima Selected Research

Hiroki Tojima Research Topics

Disease

7	Hepatocellular Carcinoma (Hepatoma) 08/2021 - 01/2007
5	Neoplasms (Cancer) 08/2021 - 01/2007
4	Fatty Liver 10/2021 - 06/2012
4	Non-alcoholic Fatty Liver Disease 10/2021 - 06/2012
3	Chronic Hepatitis C 04/2022 - 08/2011
3	Alcoholic Fatty Liver 07/2021 - 04/2011
3	Insulin Resistance 01/2019 - 03/2016
2	Hepatitis C 04/2022 - 08/2011
2	Hypertriglyceridemia 10/2021 - 07/2021
2	Virus Diseases (Viral Diseases) 01/2021 - 01/2021
2	Morbid Obesity 01/2019 - 03/2016
2	Cholestasis 01/2011 - 11/2009
2	Liver Diseases (Liver Disease) 01/2011 - 11/2009
1	Cholangiocarcinoma 07/2022
1	Esophageal and Gastric Varices (Esophageal Varices) 04/2022
1	Portal Hypertension 04/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	COVID-19 01/2022
1	Hemophilia A (Haemophilia) 12/2021
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 12/2021
1	Liver Failure 11/2021
1	Atrophy 11/2021
1	Disease Progression 10/2021
1	Liver Neoplasms (Liver Cancer) 08/2021
1	Noonan Syndrome (Female Pseudo-Turner Syndrome) 07/2021
1	Infections 01/2021
1	Ascites 10/2020
1	Body Weight Changes 07/2020
1	Fatigue 03/2020
1	Colitis 01/2019
1	Necrosis 09/2018
1	Body Weight (Weight, Body) 03/2016
1	Inflammation (Inflammations) 06/2012
1	Fibrosis (Cirrhosis) 06/2012
1	Thrombocytopenia (Thrombopenia) 08/2011
1	Hypersplenism (Anemia, Splenic) 08/2011
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2009

Drug/Important Bio-Agent (IBA)

5	AlbuminsIBA 08/2021 - 09/2015
4	Antiviral Agents (Antivirals)IBA 04/2022 - 08/2011
4	BilirubinIBA 11/2021 - 11/2009
4	lenvatinibIBA 08/2021 - 03/2020
3	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2019 - 11/2009
2	Bevacizumab (Avastin)FDA Link 07/2022 - 01/2021
2	atezolizumabIBA 07/2022 - 01/2021
2	(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA 10/2021 - 07/2021
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2021 - 03/2016
2	Alanine Transaminase (SGPT)IBA 12/2018 - 03/2016
2	Fetal Proteins (Fetoprotein)IBA 02/2018 - 09/2015
2	Choline (Choline Chloride)IBA 06/2012 - 04/2011
2	Methionine (L-Methionine)FDA Link 06/2012 - 04/2011
2	XenobioticsIBA 01/2011 - 11/2009
2	Phenobarbital (Luminal)FDA Link 01/2011 - 11/2009
2	LigandsIBA 01/2011 - 11/2009
2	Bile Acids and Salts (Bile Acids)IBA 01/2011 - 11/2009
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	glecaprevir and pibrentasvirIBA 12/2021
1	Interleukin-6 (Interleukin 6)IBA 11/2021
1	SteroidsIBA 11/2021
1	Sorafenib (BAY 43-9006)FDA Link 08/2021
1	Serum AlbuminIBA 08/2021
1	regorafenibIBA 08/2021
1	Therapeutic UsesIBA 07/2021
1	Proteins (Proteins, Gene)FDA Link 07/2021
1	Sirtuin 1IBA 07/2020
1	fibroblast growth factor 21IBA 07/2020
1	ipragliflozinIBA 07/2020
1	Sodium-Glucose Transporter 2 InhibitorsIBA 07/2020
1	LipidsIBA 07/2020
1	SirtuinsIBA 07/2020
1	CytokinesIBA 01/2019
1	1,4- bis(2- (3,5- dichloropyridyloxy))benzeneIBA 01/2019
1	Guanosine Triphosphate (GTP)IBA 01/2019
1	LDL CholesterolIBA 01/2019
1	Pregnenolone Carbonitrile (PCN)IBA 01/2019
1	Pregnane X ReceptorIBA 01/2019
1	Constitutive Androstane ReceptorIBA 01/2019
1	Triglycerides (Triacylglycerol)IBA 01/2019
1	Uric Acid (Urate)IBA 01/2019
1	Dextran SulfateIBA 01/2019
1	Benzene (Benzole)IBA 01/2019
1	HDL CholesterolIBA 01/2019
1	C-Reactive ProteinIBA 12/2018
1	Antineoplastic Agents (Antineoplastics)IBA 09/2018
1	C-PeptideIBA 03/2016
1	Hemoglobins (Hemoglobin)IBA 03/2016
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 03/2016
1	Insulin (Novolin)FDA Link 03/2016
1	Glucose (Dextrose)FDA LinkGeneric 03/2016
1	Amino Acids FDA Link 09/2015
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 09/2015
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 06/2012
1	Ribavirin (Virazole)FDA LinkGeneric 08/2011
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 04/2011
1	androstaneIBA 04/2011
1	CarcinogensIBA 04/2011
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2011
1	EnzymesIBA 11/2009

Therapy/Procedure

6	Therapeutics 04/2022 - 08/2011
2	Bariatric Surgery 01/2019 - 03/2016
1	Immunotherapy 01/2021